en
Scientific article
Open access
English

Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study

Published inAnnals of the rheumatic diseases, vol. 74, no. 6, p. 979-984
Publication date2015
Abstract

To compare the effectiveness of rituximab versus an alternative tumour necrosis factor (TNF) inhibitor (TNFi) in patients with rheumatoid arthritis (RA) with an inadequate response to one previous TNFi.

Citation (ISO format)
EMERY, P et al. Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study. In: Annals of the rheumatic diseases, 2015, vol. 74, n° 6, p. 979–984. doi: 10.1136/annrheumdis-2013-203993
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal0003-4967
458views
215downloads

Technical informations

Creation01/27/2015 3:40:00 PM
First validation01/27/2015 3:40:00 PM
Update time03/14/2023 10:45:51 PM
Status update03/14/2023 10:45:51 PM
Last indexation01/16/2024 4:28:01 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack